Pridopidine treatment in ALS: subgroup analyses from the HEALEY ALS Platform trial
Year: 2025
Type: article
Language: en
Topic: Pharmacological Receptor Mechanisms and Effects
Authors and affiliations:
raw_author_name: Michal Geva
raw_affiliation_strings: Prilenia Therapeutics B.V
Prilenia Therapeutics B.V., Naarden, The Netherlands
raw_author_name: Y. Paul Goldberg
raw_affiliation_strings: Prilenia Therapeutics B.V
Prilenia Therapeutics B.V., Naarden, The Netherlands
raw_author_name: Melanie L. Leitner
raw_affiliation_strings: Accelerating NeuroVentures, LLC
Accelerating NeuroVentures, LLC, Charlottesville, VA, USA
raw_author_name: Andres Cruz-Herranz
raw_affiliation_strings: Prilenia Therapeutics B.V
Prilenia Therapeutics B.V., Naarden, The Netherlands
raw_author_name: Randal Hand
raw_affiliation_strings: Prilenia Therapeutics B.V
Prilenia Therapeutics B.V., Naarden, The Netherlands
raw_author_name: Kelly Chen
raw_affiliation_strings: Prilenia Therapeutics B.V
Prilenia Therapeutics B.V., Naarden, The Netherlands
raw_author_name: Noga Gershoni Emek
raw_affiliation_strings: Prilenia Therapeutics B.V
Prilenia Therapeutics B.V., Naarden, The Netherlands
raw_author_name: Andrew M. Tan
raw_affiliation_strings: Department of Neurology, School of Medicine, Yale University
Prilenia Therapeutics B.V
Prilenia Therapeutics B.V., Naarden, The Netherlands
Department of Neurology, School of Medicine, Yale University, New Haven, CT, USA
raw_author_name: Sabrina Paganoni
raw_affiliation_strings: Sean M. Healey & AMG Center for ALS and Neurological Clinical Research Institute at Massachusetts General Hospital, Harvard Medical School
Spaulding Rehabilitation Hospital, Harvard Medical School
Sean M. Healey & AMG Center for ALS and Neurological Clinical Research Institute at Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
Spaulding Rehabilitation Hospital, Harvard Medical School, Boston, MA, USA
raw_author_name: James D. Berry
raw_affiliation_strings: Sean M. Healey & AMG Center for ALS and Neurological Clinical Research Institute at Massachusetts General Hospital, Harvard Medical School
Sean M. Healey & AMG Center for ALS and Neurological Clinical Research Institute at Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
raw_author_name: Eric A. Macklin
raw_affiliation_strings: Sean M. Healey & AMG Center for ALS and Neurological Clinical Research Institute at Massachusetts General Hospital, Harvard Medical School
Sean M. Healey & AMG Center for ALS and Neurological Clinical Research Institute at Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
raw_author_name: Jeremy M. Shefner
raw_affiliation_strings: Barrow Neurological Institute
Mayo Clinic
Mayo Clinic, Jacksonville, FL, USA, and
Barrow Neurological Institute, Phoenix, AZ, USA
raw_author_name: Merit E. Cudkowicz
raw_affiliation_strings: Sean M. Healey & AMG Center for ALS and Neurological Clinical Research Institute at Massachusetts General Hospital, Harvard Medical School
Sean M. Healey & AMG Center for ALS and Neurological Clinical Research Institute at Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
raw_author_name: Michael R. Hayden
raw_affiliation_strings: Department of Medical Genetics, Centre for Molecular Medicine and Therapeutics, University of British Columbia
Prilenia Therapeutics B.V
Department of Medical Genetics, Centre for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, Canada
Prilenia Therapeutics B.V., Naarden, The Netherlands